Silybin inhibits interleukin-1β-induced production of pro-inflammatory mediators in canine hepatocyte cultures

Journal of Veterinary Pharmacology and Therapeutics

Volumn 34, Issue 2, 2011, Pages 120-129

  Au, A Y ^a,b,c   Hasenwinkel, J M ^b   Frondoza, C G ^a,c,d  

^a NUTRAMAX LABORATORIES INC   (United States)

^b Syracuse University   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MISSISSIPPI STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CYTOCHROME P450 1A2; CYTOCHROME P450 3A4; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; OMEPRAZOLE; PROSTAGLANDIN E2; RIFAMPICIN; SILIBININ; SILIBININ PHOSPHATIDYLCHOLINE COMPLEX;

ANIMAL CELL; ARTICLE; CELL PROTECTION; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; CULTURE MEDIUM; CYTOPLASM; CYTOTOXICITY; LIVER CELL; LIVER CELL CULTURE; NONHUMAN; PREMEDICATION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTIOXIDANTS; CELLS, CULTURED; CHEMOKINE CCL2; DINOPROSTONE; DOGS; HEPATOCYTES; INTERLEUKIN-1BETA; INTERLEUKIN-8; NF-KAPPA B; SILYMARIN;

EID: 79952613343     PISSN: 01407783     EISSN: 13652885     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2010.01200.x     Document Type: Article

References (76)

1. Al-Anati, L., Essid, E., Reinehr, R. & Petzinger, E. (2009) Silibinin protects OTA-mediated TNF-alpha release from perfused rat livers and isolated rat Kupffer cells. Molecular Nutrition & Food Research, 53, 460-466.
2. Altin, J.G. & Bygrave, F.L. (1988) Non-parenchymal cells as mediators of physiological responses in liver. Molecular and Cellular Biochemistry, 83, 3-14 (Review).
3. Au, A.Y., Hasenwinkel, J.M. & Frondoza, C.G. (2008). Collagen biomaterial promotes hepatocyte proliferation, phenotype expression, and responsiveness to activation by pro-inflammatory stimuli. In Proceedings: World Biomaterials Congress, Amsterdam, The Netherlands.
4. Barzaghi, N., Crema, F., Gatti, G., Pifferi, G. & Perucca, E. (1990) Pharmacokinetic studies on IdB 1016, a silybin- phosphatidylcholine complex, in healthy human subjects. European journal of Drug Metabolism and Pharmacokinetics, 15, 333-338.
5. Basiglio, C.L., Sanchez Pozzi, E.J., Mottino, A.D. & Roma, M.G. (2008) Differential effects of silymarin and its active component silibinin on plasma membrane stability and hepatocellular lysis. Chemico-Biological Interactions, 179, 297-303.
6. Beckmann-Knopp, S., Rietbrock, S., Weyhenmeyer, R., Bocker, R.H., Beckurts, K.T., Lang, W., Hunz, M. & Fuhr, U. (2000) Inhibitory effects of silibinin on cytochrome P-450 enzymes in human liver microsomes. Pharmacology and Toxicology, 86, 250-256.
7. Bosisio, E., Benelli, C. & Pirola, O. (1992) Effect of the flavanolignans of Silybum marianum L. on lipid peroxidation in rat liver microsomes and freshly isolated hepatocytes. Pharmacological Research, 25, 147-154.
8. Callejas, N.A., Bosca, L., Williams, C.S., Du, B.R. & Martin-Sanz, P. (2000) Regulation of cyclooxygenase 2 expression in hepatocytes by CCAAT/enhancer-binding proteins. Gastroenterology, 119, 493-501.
9. Carini, R., Comoglio, A., Albano, E. & Poli, G. (1992) Lipid peroxidation and irreversible damage in the rat hepatocyte model. Protection by the silybin-phospholipid complex IdB 1016. Biochemical Pharmacology, 43, 2111-2115.
10. Casado, M., Callejas, N.A., Rodrigo, J., Zhao, X., Dey, S.K., Bosca, L. & Martin-Sanz, P. (2001) Contribution of cyclooxygenase 2 to liver regeneration after partial hepatectomy. The FASEB Journal, 15, 2016-2018.
11. Castell, J.V. & Gomez-Lechon, M.J. (2009) Liver cell culture techniques. Methods in Molecular Biology (Clifton, N.J.), 481, 35-46 (Review).
12. Celsis International Ltd. (20082010). Plateable hepatocytes. In In Vitro ADME-Tox. Celsis International Ltd, Baltimore.
13. Center, S.A. (2004) Metabolic, antioxidant, nutraceutical, probiotic, and herbal therapies relating to the management of hepatobiliary disorders. Veterinary Clinics of North America. Small Animal Practice, 34, 67-172, vi.
14. Comoglio, A., Leonarduzzi, G., Carini, R., Busolin, D., Basaga, H., Albano, E., Tomasi, A., Poli, G., Morazzoni, P. & Magistretti, M.J. (1990) Studies on the antioxidant and free radical scavenging properties of IdB 1016 a new flavanolignan complex. Free Radical Research Communications, 11, 109-115.
15. Daniluk, J., Szuster-Ciesielska, A., Drabko, J. & Kandefer-Szerszen, M. (2001) Serum cytokine levels in alcohol-related liver cirrhosis. Alcohol (Fayetteville, N.Y.), 23, 29-34.
16. Dasarathy, S. (2008) Inflammation and liver. Journal of Parenteral and Enteral Nutrition, 32, 660-666.
17. Dehmlow, C., Erhard, J. & de Groot, H. (1996) Inhibition of Kupffer cell functions as an explanation for the hepatoprotective properties of silibinin. Hepatology, 23, 749-754.
18. Detaille, D., Sanchez, C., Sanz, N., Lopez-Novoa, J.M., Leverve, X. & El-Mir, M.Y. (2008) Interrelation between the inhibition of glycolytic flux by silibinin and the lowering of mitochondrial ROS production in perifused rat hepatocytes. Life Sciences, 82, 1070-1076.
19. Di Sario, A., Bendia, E., Taffetani, S., Omenetti, A., Candelaresi, C., Marzioni, M., De Minicis, S. & Benedetti, A. (2005) Hepatoprotective and antifibrotic effect of a new silybin-phosphatidylcholine-Vitamin E complex in rats. Digestive and Liver Disease, 37, 869-876.
20. Dunn, J.C., Yarmush, M.L., Koebe, H.G. & Tompkins, R.G. (1989) Hepatocyte function and extracellular matrix geometry: long-term culture in a sandwich configuration. The FASEB Journal, 3, 174-177.
21. Dvorak, Z., Kosina, P., Walterova, D., Simanek, V., Bachleda, P. & Ulrichova, J. (2003) Primary cultures of human hepatocytes as a tool in cytotoxicity studies: cell protection against model toxins by flavonolignans obtained from Silybum marianum. Toxicology Letters, 137, 201-212.
22. Falasca, K., Ucciferri, C., Mancino, P., Vitacolonna, E., De Tullio, D., Pizzigallo, E., Conti, P. & Vecchiet, J. (2008) Treatment with silybin-vitamin E-phospholipid complex in patients with hepatitis C infection. Journal of Medical Virology, 80, 1900-1906.
23. Farghali, H., Kamenikova, L., Hynie, S. & Kmonickova, E. (2000) Silymarin effects on intracellular calcuim and cytotoxicity: a study in perfused rat hepatocytes after oxidative stress injury. Pharmacological Research, 41, 231-237.
24. Fiegel, H.C., Havers, J., Kneser, U., Smith, M.K., Moeller, T., Kluth, D., Mooney, D.J., Rogiers, X. & Kaufmann, P.M. (2004) Influence of flow conditions and matrix coatings on growth and differentiation of three-dimensionally cultured rat hepatocytes. Tissue Engineering, 10, 165-174.
25. Filburn, C.R., Kettenacker, R. & Griffin, D.W. (2007) Bioavailability of a silybin-phosphatidylcholine complex in dogs. Journal of Veterinary Pharmacology and Therapeutics, 30, 132-138.
26. Fisher, N.C., Neil, D.A., Williams, A. & Adams, D.H. (1999) Serum concentrations and peripheral secretion of the beta chemokines monocyte chemoattractant protein 1 and macrophage inflammatory protein 1alpha in alcoholic liver disease. Gut, 45, 416-420.
27. He, Q., Kim, J. & Sharma, R.P. (2004) Silymarin protects against liver damage in BALB/c mice exposed to fumonisin B1 despite increasing accumulation of free sphingoid bases. Toxicological Sciences, 80, 335-342.
28. Henkel, J., Neuschafer-Rube, F., Pathe-Neuschafer-Rube, A. & Puschel, G.P. (2009) Aggravation by prostaglandin E2 of interleukin-6-dependent insulin resistance in hepatocytes. Hepatology, 50, 781-790.
29. Hill, D., Shedlofsky, S., McClain, C., Diehl, A.M. & Tsukamoto, H. (1997) Cytokines and liver disease. In Cytokines in Health and Disease, 2nd edn. Eds Remick, D.G. & Friedland, J.S., pp. 401-425. Marcel Dekker Inc., New York.
30. Hoek, J.B. & Rubin, E. (1999) Intracellular signal transduction in liver regeneration. In Liver Growth and Repair. Eds Strain, A. & Diehl, A.M., pp. 366-401. Thompson Science Publishers, London.
31. Hsieh, C.S., Huang, C.C., Wu, J.J., Chaung, H.C., Wu, C.L., Chang, N.K., Chang, Y.M., Chou, M.H. & Chuang, J.H. (2001) Ascending cholangitis provokes IL-8 and MCP-1 expression and promotes inflammatory cell infiltration in the cholestatic rat liver. Journal of Pediatric Surgery, 36, 1623-1628.
32. Izeboud, C.A., Hoebe, K.H., Grootendorst, A.F., Nijmeijer, S.M., van Miert, A.S., Witkamp, R.R. & Rodenburg, R.J. (2004) Endotoxin-induced liver damage in rats is minimized by beta 2-adrenoceptor stimulation. Inflammation Research, 53, 93-99.
33. Jomphe, C., Gabriac, M., Hale, T.M., Heroux, L., Trudeau, L.E., Deblois, D., Montell, E., Verges, J. & du Souich, P. (2008) Chondroitin sulfate inhibits the nuclear translocation of nuclear factor-kappaB in interleukin-1beta-stimulated chondrocytes. Basic & Clinical Pharmacology & Toxicology, 102, 59-65.
34. Kang, Y.H., Berthiaume, F. & Yarmush, M.L. (2002) Long-term stable cultures of rat hepatocytes: an in vitro model to study acute and chronic hepatic inflammation. Tissue Engineering, 8, 681-693.
35. Kang, J.S., Jeon, Y.J., Park, S.K., Yang, K.H. & Kim, H.M. (2004) Protection against lipopolysaccharide-induced sepsis and inhibition of interleukin-1beta and prostaglandin E2 synthesis by silymarin. Biochemical Pharmacology, 67, 175-181.
36. Kaplanski, G., Farnarier, C., Payan, M.J., Bongrand, P. & Durand, J.M. (1997) Increased levels of soluble adhesion molecules in the serum of patients with hepatitis C. Correlation with cytokine concentrations and liver inflammation and fibrosis. Digestive Diseases and Sciences, 42, 2277-2284.
37. Kataropoulou, M., Henderson, C. & Grant, M.H. (2005) Metabolic studies of hepatocytes cultured on collagen substrata modified to contain glycosaminoglycans. Tissue Engineering, 11, 1263-1273.
38. Kidd, P. & Head, K. (2005) A review of the bioavailability and clinical efficacy of milk thistle phytosome: a silybin-phosphatidylcholine complex (Siliphos). Alternative Medicine Review, 10, 193-203.
39. Koj, A. & Jura, J. (2003) Complex analysis of genes involved in the inflammatory response: interleukin-1-induced differential transcriptome of cultured human hepatoma HepG2 cells. Acta Biochimica Polonica, 50, 573-582.
40. Kosina, P., Maurel, P., Ulrichova, J. & Dvorak, Z. (2005) Effect of silybin and its glycosides on the expression of cytochromes P450 1A2 and 3A4 in primary cultures of human hepatocytes. Journal of Biochemical and Molecular Toxicology, 19, 149-153.
41. Kuzumoto, Y., Sho, M., Ikeda, N., Hamada, K., Mizuno, T., Akashi, S., Tsurui, Y., Kashizuka, H., Nomi, T., Kubo, A., Kanehiro, H. & Nakajima, Y. (2005) Significance and therapeutic potential of prostaglandin E2 receptor in hepatic ischemia/reperfusion injury in mice. Hepatology, 42, 608-617.
42. Kvasnicka, F., Biba, B., Sevcik, R., Voldrich, M. & Kratka, J. (2003) Analysis of the active components of silymarin. Journal of Chromatography. A, 990, 239-245.
43. Largo, R., Alvarez-Soria, M.A., Diez-Ortego, I., Calvo, E., Sanchez-Pernaute, O., Egido, J. & Herrero-Beaumont, G. (2003) Glucosamine inhibits IL-1beta-induced NFkappaB activation in human osteoarthritic chondrocytes. Osteoarthritis and Cartilage/OARS, Osteoarthritis Research Society, 11, 290-298.
44. Manna, S.K., Mukhopadhyay, A., Van, N.T. & Aggarwal, B.B. (1999) Silymarin suppresses TNF-induced activation of NF-kappa B, c-Jun N-terminal kinase, and apoptosis. Journal of Immunology, 163, 6800-6809.
45. Marra, F. (2002) Chemokines in liver inflammation and fibrosis. Frontiers in Bioscience, 7, d1899-d1914.
46. Mayoral, R., Molla, B., Flores, J.M., Bosca, L., Casado, M. & Martin-Sanz, P. (2008) Constitutive expression of cyclo-oxygenase 2 transgene in hepatocytes protects against liver injury. The Biochemical Journal, 416, 337-346.
47. McClain, C.J., Shedlofsky, S., Barve, S. & Hill, D.B. (1997) Cytokines and alcoholic liver disease. Alcohol Health and Research World, 21, 317-320.
48. Mion, F., Jasuja, R. & Johnston, D.E. (1995) The contribution of hepatocytes to prostaglandin synthesis in rat liver. Prostaglandins, Leukotrienes, and Essential Fatty Acids, 53, 109-115.
49. Morazzoni, P., Magistretti, M.J., Giachetti, C. & Zanolo, G. (1992) Comparative bioavailability of Silipide, a new flavanolignan complex, in rats. European Journal of Drug Metabolism and Pharmacokinetics, 17, 39-44.
50. Noursadeghi, M., Tsang, J., Haustein, T., Miller, R.F., Chain, B.M. & Katz, D.R. (2008) Quantitative imaging assay for NF-kappaB nuclear translocation in primary human macrophages. Journal of Immunological Methods, 329, 194-200.
51. Ohira, H., Ueno, T., Torimura, T., Tanikawa, K. & Kasukawa, R. (1995) Leukocyte adhesion molecules in the liver and plasma cytokine levels in endotoxin-induced rat liver injury. Scandinavian Journal of Gastroenterology, 30, 1027-1035.
52. Perez, S., Maldonado, E.N., Aspichueta, P., Ochoa, B. & Chico, Y. (2004) Differential modulation of prostaglandin receptor mRNA abundance by prostaglandins in primary cultured rat hepatocytes. Molecular and Cellular Biochemistry, 266, 183-189.
53. Piston, D., Wang, S., Feng, Y., Ye, Y.J., Zhou, J., Jiang, K.W., Xu, F., Zhao, Y. & Cui, Z.R. (2007) The role of cyclooxygenase-2/prostanoid pathway in visceral pain induced liver stress response in rats. Chinese Medical Journal, 120, 1813-1819.
54. Polyak, S.J., Khabar, K.S., Rezeiq, M. & Gretch, D.R. (2001) Elevated levels of interleukin-8 in serum are associated with hepatitis C virus infection and resistance to interferon therapy. Journal of Virology, 75, 6209-6211.
55. Ram, V.J. (2001) Herbal preparations as a source of hepatoprotective agents. Drug News & Perspectives, 14, 353-363.
56. Ramadori, G. & Armbrust, T. (2001) Cytokines in the liver. European Journal of Gastroenterology & Hepatology, 13, 777-784 (Review).
57. Sass, G., Koerber, K. & Tiegs, G. (2002) TNF tolerance and cytotoxicity in the liver: the role of interleukin-1beta, inducible nitric oxide-synthase and heme oxygenase-1 in D-galactosamine-sensitized mice. Inflammation Research, 51, 229-235.
58. Schandalik, R., Gatti, G. & Perucca, E. (1992) Pharmacokinetics of silybin in bile following administration of silipide and silymarin in cholecystectomy patients. Arzneimittel-Forschung, 42, 964-968.
59. Schoemaker, M.H. & Moshage, H. (2004) Defying death: the hepatocyte's survival kit. Clinical Science (London, England), 107, 13-25 (Review).
60. Scotte, M., Masson, S., Lyoumi, S., Hiron, M., Teniere, P., Lebreton, J.P. & Daveau, M. (1997) Cytokine gene expression in liver following minor or major hepatectomy in rat. Cytokine, 9, 859-867.
61. Shi, X.L., Qiu, Y.D., Li, Q., Xie, T., Zhu, Z.H., Chen, L.L., Li, L. & Ding, Y.T. (2005) Hepatocyte-like cells from directed differentiation of mouse bone marrow cells in vitro. Acta Pharmacologica Sinica, 26, 469-476.
62. Smith, L. (2009). In Canine Liver Disease Foundation. Available at: (accessed on 4 June 2010)
63. Sonnenbichler, J. & Zetl, I. (1984) Mechanism of action of silibinin. Effect of silibinin on the synthesis of ribosomal RNA, mRNA and tRNA in rat liver in vivo. Hoppe-Seyler's Zeitschrift für Physiologische Chemie, 365, 555-566.
64. Sowa, J.P., Best, J., Benko, T., Bockhorn, M., Gu, Y., Niehues, E.M., Bucchi, A., Benedetto-Castro, E.M., Gerken, G., Rauen, U. & Schlaak, J.F. (2008) Extent of liver resection modulates the activation of transcription factors and the production of cytokines involved in liver regeneration. World Journal of Gastroenterology, 14, 7093-7100.
65. Suh, H.N., Lee, Y.J. & Han, H.J. (2009) Interleukin-6 promotes 2-deoxyglucose uptake through p44/42 MAPKs activation via Ca2+/PKC and EGF receptor in primary cultured chicken hepatocytes. Journal of Cellular Physiology, 218, 643-652.
66. Svagera, Z., Skottova, N., Vana, P., Vecera, R., Urbanek, K., Belejova, M., Kosina, P. & Simanek, V. (2003) Plasma lipoproteins in transport of silibinin, an antioxidant flavonolignan from Silybum marianum. Phytotherapy Research, 17, 524-530.
67. Tateno, C. & Yoshizato, K. (1996) Growth and differentiation in culture of clonogenic hepatocytes that express both phenotypes of hepatocytes and biliary epithelial cells. The American Journal of Pathology, 149, 1593-1605.
68. Tedesco, D., Domeneghini, C., Sciannimanico, D., Tameni, M., Steidler, S. & Galletti, S. (2004) Silymarin, a possible hepatoprotector in dairy cows: biochemical and histological observations. Journal of Veterinary Medicine. A, Physiology, Pathology, Clinical Medicine, 51, 85-89.
69. Treffkorn, L., Scheibe, R., Maruyama, T. & Dieter, P. (2004) PGE2 exerts its effect on the LPS-induced release of TNF-alpha, ET-1, IL-1alpha, IL-6 and IL-10 via the EP2 and EP4 receptor in rat liver macrophages. Prostaglandins & Other Lipid Mediators, 74, 113-123.
70. Tsukamoto, H. (1999) Cytokine regulation of hepatic stellate cells in liver fibrosis. Alcoholism, Clinical and Experimental Research, 23, 911-916.
71. Tuschl, G., Lauer, B. & Mueller, S.O. (2008) Primary hepatocytes as a model to analyze species-specific toxicity and drug metabolism. Expert Opinion on Drug Metabolism & Toxicology, 4, 855-870.
72. Valenzuela, A., Aspillaga, M., Vial, S. & Guerra, R. (1989) Selectivity of silymarin on the increase of the glutathione content in different tissues of the rat. Planta Medica, 55, 420-422.
73. Vogel, G., Tuchweber, B., Trost, W. & Mengs, U. (1984) Protection by silibinin against Amanita phalloides intoxication in beagles. Toxicology and Applied Pharmacology, 73, 355-362.
74. Wu, J.W., Lin, L.C. & Tsai, T.H. (2009) Drug-drug interactions of silymarin on the perspective of pharmacokinetics. Journal of Ethnopharmacology, 121, 185-193.
75. Zeisberg, M., Kramer, K., Sindhi, N., Sarkar, P., Upton, M. & Kalluri, R. (2006) De-differentiation of primary human hepatocytes depends on the composition of specialized liver basement membrane. Molecular and Cellular Biochemistry, 283, 181-189.
76. Zhao, J. & Agarwal, R. (1999) Tissue distribution of silibinin, the major active constituent of silymarin, in mice and its association with enhancement of phase II enzymes: implications in cancer chemoprevention. Carcinogenesis, 20, 2101-2108.